We offer the services for in vitro and in vivo models to improve the efficacy and safety evaluation for new drugs for biotechnology, pharmaceutical and consumer healthcare companies. Our expertise in developing predictive preclinical models helps to reduce the time and cost of product development and minimize the risks of downstream testing.
